These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7106173)

  • 1. Changes in nalorphine-induced hyperprolactinaemia after bromocriptine or sulpiride administration.
    Barreca T; Magnani G; Sannia A; Rolandi E
    Eur J Clin Pharmacol; 1982; 22(4):375-6. PubMed ID: 7106173
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
    Delitala G
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of sulfpride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo.
    Hofmann M; Battaini F; Tonon G; Trabucchi M; Spano P
    Eur J Pharmacol; 1979 Jun; 56(1-2):15-20. PubMed ID: 467503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modifications of the incretory pituitary response of prolactin to sulpiride after treatment with bromocryptin].
    Gianrossi R; Gallamini A; Nizzo MC; Murialdo G; Peirano L
    Boll Soc Ital Biol Sper; 1976 Oct; 52(19):1568-71. PubMed ID: 1037380
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of cyclic AMP in the action of dopaminergic D2 receptors of some endocrine glands in rats.
    Abu-Jayyab A; el-Denshary EE; Ageel AM; Dakkak MR
    Biosci Rep; 1987 Oct; 7(10):751-5. PubMed ID: 2833951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a dopaminergic activity of methysergide in humans.
    Oppizzi G; Verde G; De Stefano L; Cozzi R; Botalla L; Liuzzi A; Chiodini PG
    Clin Endocrinol (Oxf); 1977 Oct; 7(4):267-72. PubMed ID: 923106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oestrogen-induced hyperprolactinaemia in the rat: reduced concentrations of hypothalamic dopamine and the effects of bromocriptine.
    Smythe GA; Brandstater JF
    Aust J Biol Sci; 1980 Jun; 33(3):329-39. PubMed ID: 7425967
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experimental study of sulpiride-bromocriptine association on the female rat estrous cycle (author's transl)].
    Valli M; Bruguerolle B; Jadot G; Bouyard P
    Ann Endocrinol (Paris); 1981; 42(1):49-55. PubMed ID: 7198424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin involvement with the increase in seminal volume after sexual stimulation in stallions.
    Thomson CH; Thompson DL; Kincaid LA; Nadal MR
    J Anim Sci; 1996 Oct; 74(10):2468-72. PubMed ID: 8904716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.
    Karlsson G; Jaton AL; Vigouret JM
    Neurosci Lett; 1988 May; 88(1):69-74. PubMed ID: 2969468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of changes in serum concentrations of prolactin and testosterone during dopaminergic modulation in males.
    Nakagawa K; Obara T; Matsubara M; Kubo M
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):345-52. PubMed ID: 6814794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    Tissari AH; Rossetti ZL; Meloni M; Frau MI; Gessa GL
    Eur J Pharmacol; 1983 Aug; 91(4):463-8. PubMed ID: 6413231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of dopamine receptors (type 2) lowers human intraocular pressure.
    Mekki QA; Turner P
    Br J Ophthalmol; 1985 Dec; 69(12):909-10. PubMed ID: 4084483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine.
    Gomaa AA; Mohamed LH; Ahmed HN
    Eur J Pharmacol; 1989 Nov; 170(3):129-35. PubMed ID: 2620694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine inhibits salsolinol-induced prolactin release in male goats.
    Hashizume T; Sawada T; Nakajima Y; Yaegashi T; Saito H; Goto Y; Jin J; Fülöp F; Nagy GM
    Anim Sci J; 2012 Jan; 83(1):63-7. PubMed ID: 22250741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of physiologic and pharmacologic agents on serum prolactin concentrations in the nonpregnant mare.
    Johnson AL; Becker SE
    J Anim Sci; 1987 Nov; 65(5):1292-7. PubMed ID: 3121569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal pattern of the TSH and PRL responses to dopamine receptor blockade in women with physiological or pathological hyperprolactinaemia.
    Massara F; Camanni F; Martra M; Dolfin GC; Müller EE; Molinatti GM
    Clin Endocrinol (Oxf); 1983 Feb; 18(2):103-10. PubMed ID: 6851194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stereospecificity of hypothalamo-hypophysial dopamine receptors involved in the control of prolactin secretion in normal man: effects of sulpiride stereoisomers].
    Benfenati F; De Camillis E; Cortelli P; Orlandi F
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1226-32. PubMed ID: 7459063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bromocriptine-induced inhibition of plasma dopamine, noradrenaline and adrenaline responses to LH-RF.
    Van Loon GR
    Nature; 1978 Sep; 275(5678):331-2. PubMed ID: 357990
    [No Abstract]   [Full Text] [Related]  

  • 20. Restoration of the prolactin response to sulpiride by metergoline administration in hyperprolactinemic patients.
    Ferrari C; Travaglini P; Caldara R; Moriondo P; Mattei A; Crosignani PG; Faglia G
    Neuroendocrinology; 1979; 29(5):338-45. PubMed ID: 503288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.